Engineering biology | Interpreting complexity 
Accelerating impact

We are NEXYRA

Nexyra Advanced Research is a deep tech company pioneering the integration of omics sciences, artificial intelligence, and systems biology to decode complexity in life sciences and deliver actionable biomedical insights.

Founded by scientists, technologists, and entrepreneurs, Nexyra exists to bridge the gap between biological data and meaningful human impact — from early discovery to real-world application.

Decoding life

with high-throughput, multi-omics analysis

Engineering data 

workflows that automate and accelerate biomedical discovery

Empowering decisions

with AI-ready, clinically actionable knowledge

What Drives Us

We believe the future of healthcare, diagnostics, and therapeutic innovation lies in our ability to understand biology as a system — and to do so at scale.

What We Do

Bioinformatics

Scalable pipelines for omics processing and data standardization.

01

AI + Systems Biology

Predictive modeling, pattern recognition, and multi-omics integration.

02

Data Infrastructure

Building OmixCloud: a next-gen digital biobank and biomedical data hub.

03

Scientific Services

End-to-end support: from sample logistics to custom interpretative reports, specialized training and consulting.

04

Our Vision

To transform complex biological data into a catalyst for human progress, enabling faster discoveries, smarter decisions, and better outcomes across healthcare, pharma, and public health.

Join Our Mission

Whether you're a researcher, partner, or visionary — we invite you to collaborate, co-create, and explore the frontier of omics and biomedical science with us.

Legal Notice    Privacy Policy

 

© Copyright – All rights reserved.

Necesitamos su consentimiento para cargar las traducciones

Utilizamos un servicio de terceros para traducir el contenido del sitio web que puede recopilar datos sobre su actividad. Por favor revise los detalles en la política de privacidad y acepte el servicio para ver las traducciones.